ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
Tips to a Successful Monitoring Visit
Analysis of HRPP & RDCP Routine Reviews Calendar Year 2010 Frequent Findings Aileen Ward and Bob Brooks HRPP 201 Orlando Florida March 24, 2010.
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
The Institutional Review Board. What is an IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
The Consent Process: It’s More Than Just a Form A “10 Minute Training” Brought to you by Cyndi Long, MS, RD, CCRC CU Sports Medicine.
IRB Review Mechanics: Looking under the hood IRB Administrators 2012 PRIDE Lucindia Shouse, MS, CIP May 31, 2012.
Office of Research Oversight. Working Group Report Slide 2.
Office of Research Oversight. Challenges & Opportunities Related to “Collaborative” Research with Affiliates Challenges –Federal Records Retention Requirements.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
VHA Handbook K. Lynn Cates, M.D. Assistant Chief Research & Development Officer Director, PRIDE HRPP 201 March 24, 2011.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
John Naim, PhD Director Clinical Trials Research Unit
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
Office of Research Oversight VHA Handbook Research Conducted by VHA Program Office Employees Effective May 1, 2012 October 28, 2011.
VA Research: IRB and R&D Approval Process From Initial Submission, Through the Informed Consent Process and Continuing Review, To Inactivation Kimberly.
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
2012 VA IRB Administrators Meeting Stephania H. Griffin, JD, RHIA, CIPP/G VHA Privacy Officer Director, Information Access and Privacy Privacy Officer.
Reality vs Urban Myth: The Truth About Regulations
Syracuse VAMC HRPP Office Serving Bath, Canandaigua &
Federalwide Assurance Presentation for IRB Members.
Who’s the Boss? Faculty Advisor or Principal Investigator Supervision versus Student Investigator or Study Coordinator Responsibilities Gwenn Snow, MS,
Response to FDA Audit 483 MX-4501N : Nine Category 483 Citations Meetings Minutes: Votes for, against, abstention and reason not recorded;
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Research and Development Protocol Submission and Continuing Review Processes Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas.
Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Developing Solutions - Specific ISO & Privacy Officer Responsibilities for Review of Human Research Projects K. Lynn Cates, M.D. Assistant Chief Research.
AAHRPP Association for the Accreditation of Human Research Protection Programs Thanks to: Lisa Demanuel, Program Specialist Brain Rehabilitation Research.
ORO Reviews: Frequent Findings Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight May, 2012.
Privacy Officer Core Responsibilities for Human Research Protection Stephania H. Griffin, RHIA, CIPP/G VHA Privacy Officer.
Questions: AAHRPP Evaluation Instrument for Use with Final Revised Accreditation Standards Presented by: C. Karen Jeans, MSN, CCRN, CIP COACH Program Analyst,
Read the SMALL PRINT of the 1572 The Essential GCP Document.
VA Central IRB Annette R. Anderson, MS, RHIA, CIP VA Central IRB Administrator HRPP 101, September 2010.
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Human Research Protection Program & IRB Responsibilities Marisue Cody, PhD Director Center on Advice & Compliance Help.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
Office of Research Oversight 1 ORO Research Suspensions and Other ACOS/R Concerns Tom Puglisi, PhD Local Accountability in Research April 8, 2010.
1 Role of the Privacy Officer on the IRB Stephania H. Griffin, RHIA, CIPP/G VHA Privacy Officer.
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
VA Central IRB Annette R. Anderson, MS, RHIA, CIP VA Central IRB Administrator Local Accountability Meeting June 2011.
What Institutional Researchers Should Know about the IRB Susan Thompson Senior Research Analyst Office of Institutional Research Presented at the Texas.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
Office of Research Oversight 1 Office of Research and Development Local Accountability Meeting January 2009.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
1 Role of the Privacy Office in VA Research Stephania H. Putt VHA Privacy Officer.
Welcome New IRB Member! This brief presentation covers: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
VA HRPP Accreditation October 18, 2011 Accreditation Conference Call PRIDE/Soundia Duche, MA, MS.
INVESTIGATOR RESPONSIBILITIES C. Karen Jeans, MSN COACH Project Analyst.
Non-compliance with Human Subjects Research Regulations J. Bruce Smith, MD, CIP November 2014 Continuing Education for IRB Members.
1 Research & Development Committee Brenda Cuccherini, Ph.D., MPH Office of Research & Development January 2007.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.
Informed Consent Presented by Marian Serge, RN. Goals Informed consent process and form Title 38 CFR , Common Rule required elements and additional.
Conditional IRB Approval
Research Compliance and Institutional Review Boards
COCE Institutional Review Board Academic Spotlight
Beverley Alberola, CIP Associate Director, Research Protections
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Office of Research Integrity and Protections
Presentation transcript:

ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight May, 2012

ORO Reviews 2010 Most Frequently Cited Concerns about IRBs 1. IRB policies contained information that was outdated or inconsistent with current VHA policies. (53%) 2. Research personnel and/or oversight committee members did not complete required training. (38%) 3. Research personnel conducted research without a research scope of practice and/or current scopes of practice for all non-privileged research personnel were not retained in the Research Office. (38%) 4. The ISO and PO did not thoroughly review research protocols and document their reviews. (31%) 5. The informed consent document approved by the IRB did not contain all required elements. (25%)

ORO Reviews 2009 Most Frequently Cited Concerns about IRBs 1. Performing annual on-going reviews of all protocols 2. Effective systems to track protocols, staff, and subjects 3. System for assuring credentialing, scopes of practice, and research-related training is effective and info is current (2010) 4. Communication between IRB and R&DC, especially if IRB is at the affiliate institution 5. Issues with the ISO and PO, training and protocol review (2010) 6. Reporting of SAEs and SCN to ORO in a timely manner

ORO Reviews 2005 Most Frequently Cited Concerns re IRBs 1. IRB votes do not distinguish recusal from abstention 2. IRB violates SOPs re expedited reviews and waiver of consent 3. IRB members do not have adequate knowledge 4. Informed Consent Documents do not follow SOPs

Routine Reviews Most Frequently Cited Concerns re IRBs 1. Failure to Obtain Written Informed Consent 2. Failure to follow IRB-approved research protocol 3. Beginning research prior to R&DC approval 4. Inadequate staff to support the HRPP program 5. Inadequate tracking system for protocols 6. Failure to maintain records for at least 3 years after closure 7. Reviews of Serious Adverse Events not documented

IRB SOPs FOXTROT VAMC IRB has the following language in their SOP: “The IRB Coordinator serves as the alternate voting IRB, non-scientific, and affiliated member.” IS THIS IRB POLICY COMPLIANT WITH ALL VHA REQUIREMENTS?

IRB SOPs “The IRB Coordinator serves as the alternate voting IRB, non-scientific, and affiliated member.” VHA Handbook §12 (j) stipulates that “R&D Administration officials including, but not limited to the ACOS for R&D and the AO for R&D, may not serve as voting members of the IRB.” This prohibition extends to IRB coordinators and administrators.

IRB SOPs “The IRB Coordinator serves as the alternate voting IRB, non-scientific, and affiliated member.” What if the IRB is at the VA’s affiliate, and the IRB coordinator is an employee of the medical affiliate (not a VA employee.) DOES THIS CHANGE THE ANSWER?

IRB SOPs The IRB approval letter stated: “Research records must be retained for three years after completion of the research, if the study involves medical treatment; it is recommended that the records be retained for eight years.” IS THIS LANGUAGE COMPLIANT WITH ALL VHA REQUIREMENTS?

IRB SOPs VHA Handbook §26(h) Record Retention “The required records, including the investigator’s research records, must be retained until disposition instructions are approved by the National Archives and Records Administration (NARA) and are published in VHA's Records Control Schedule (RCS 10-1).”

TRAINING LAPSES ORO noted that three active research personnel did not maintain mandatory training requirements. Review of Personnel Training Records revealed that 17 out of 239 active research study personnel (7.1%) lapsed in their required trainings. Review of training records revealed that the records were accurate and up-to-date. However, 14 out of 117 active research study personnel (12%) lapsed in their required trainings.

TRAINING LAPSES VHA Handbook §61 b.” All individuals who are subject to this Handbook are required to: (1) Complete training in GCP and the ethical principles on which human research is to be conducted before they may participate in human subjects research, and (2) Update such training every 2 years thereafter.” c. “It is the responsibility of the VA facility Director, or designee, to develop local SOPs, to provide documentation that the biennial requirements are met for GCP”

SCOPES OF PRACTICE The VAMC Research Office was unable to produce documentation of active research staff and their required training.

SCOPES OF PRACTICE VHA Handbook § 5.a(6) requires the local Research Office to maintain accurate, up-to-date records regarding the mandatory training and credentialing of investigators and other appropriate research staff in the protection of human research subjects. [§61.a.2]

SCOPES OF PRACTICE Scope of Practice statements not required for all personnel. The VAMC IRB SOP only requires Scopes of Practice for persons designated as “Others to Assist,” and does not require them for co-investigators and PIs.

ISO and PO reviews ISO/PO Review protocols not documented. ISO carried out protocol reviews but did not have a formal mechanism to document the results of these reviews. The ISOs and PO were only reviewing the application forms, not verifying assertions/statements made by investigators in the applications by examining the protocols, consent forms and other source documents included in review submissions. [§38]

ISO and PO reviews The Privacy Officer and the ISO are responsible for: a. Ensuring the proposed research complies with all applicable local, VA and other Federal requirements for privacy and confidentiality, and for information security, respectively, by identifying, addressing, and mitigating potential concerns about proposed research studies, and by serving in an advisory capacity to the IRB or R&D Committee as a nonvoting member. b. Reviewing the proposed study protocol and any other relevant materials submitted with the IRB application.

ISO and PO reviews NOTE: It is not sufficient for the Privacy Officer or ISO to review a checklist completed by the investigator, and not the study protocol and related materials themselves.

Required Informed Consent Elements VHA Handbook §31: a.10(b) Research-related injury (even minimal risk!) b. 3 The Sponsor of the Study. For FDA-regulated studies, statement about clinicaltrials.gov required by the FDA

Required Informed Consent Elements The Common Rule at 38 CFR 16 § 116(a)(6) requires that the consent process include an explanation as to whether any medical treatments are available if injury occurs for studies of more than minimal risk The VA regulation at 38 CFR 17 § 85 requires the VA to provide necessary treatment for all subjects injured as a result of research participation,- even for minimal risk studies

Required Informed Consent Elements For FDA-regulated studies, statement about clinicaltrials.gov required by the FDA "applicable clinical trials": Trials of Drugs and Biologics: Controlled, clinical investigations, other than Phase I investigations, of a product subject to FDA regulation; Trials of Devices: Controlled trials with health outcomes of a product subject to FDA regulation (other than small feasibility studies) and pediatric postmarket surveillance studies.

Required Informed Consent Elements For FDA-regulated studies, statement about clinicaltrials.gov required by the FDA: